Literature DB >> 23886227

Association of childhood attention-deficit/hyperactivity disorder with atopic diseases and skin infections? A matched case-control study using the General Practice Research Database.

Eelko Hak1, Tjalling W de Vries, Pieter J Hoekstra, Susan S Jick.   

Abstract

BACKGROUND: Data to support the hypothesis of a relationship between attention-deficit/hyperactivity disorder (ADHD) and allergies are conflicting.
OBJECTIVE: To assess whether children with ADHD are more likely to have a history of atopic disorders, skin infections, and medical prescriptions than children without ADHD.
METHODS: We conducted a nested case-control study among boys using the UK General Practice Research Database (GPRD). Cases were defined as children with first-time diagnosis of ADHD who were treated with methylphenidate. Four controls who had neither ADHD nor ADHD drug prescriptions in their medical records were matched to each case on age and general practice.
RESULTS: We identified 884 boys with a first-time diagnosis of drug-treated ADHD and 3,536 controls. The independent odds ratios adjusted for age and presence of low birth weight or preterm delivery were 1.4 (95% confidence interval [CI], 1.2-1.7; P < .001) for a medical history of asthma, 1.5 (95% CI, 1.3-1.9; P < .001) for impetigo, and 1.5 (95% CI, 1.3-1.7; P < .001) for any antihistamine drug prescriptions. Other exposures that were more common in cases than controls, though not independently, were cow's milk intolerance and any prescription from the drug categories antiasthmatics, respiratory corticosteroids, topical steroids, antibacterials, or antifungals.
CONCLUSION: Despite possible limitations inherent to observational studies, this study lends support to the emerging evidence that childhood ADHD is associated with atopic diseases and impetigo. Further interdisciplinary research is needed to understand the underlying mechanisms and to evaluate targeted preventive, diagnostic, and therapeutic interventions.
Copyright © 2013 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23886227     DOI: 10.1016/j.anai.2013.05.023

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  14 in total

1.  In utero exposure to β-2-adrenergic receptor agonist and attention-deficit/hyperactivity disorder in children.

Authors:  Hong Liang; Jianping Chen; Maohua Miao; Jakob Christensen; Søren Dalsgaard; Wei Yuan; Jiong Li
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-02-09       Impact factor: 4.785

2.  Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study.

Authors:  H-C Kuo; W-C Chang; L-J Wang; S-C Li; W-P Chang
Journal:  Epidemiol Psychiatr Sci       Date:  2015-09-22       Impact factor: 6.892

Review 3.  Childhood Physical Health and Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Modifiable Factors.

Authors:  Marvin So; Eric J Dziuban; Caitlin S Pedati; Joseph R Holbrook; Angelika H Claussen; Brenna O'Masta; Brion Maher; Audrey A Cerles; Zayan Mahmooth; Laurel MacMillan; Jennifer W Kaminski; Margaret Rush
Journal:  Prev Sci       Date:  2022-08-10

4.  Anxiety-like behavior and intestinal microbiota changes as strain-and sex-dependent sequelae of mild food allergy in mouse models of cow's milk allergy.

Authors:  Nicholas A Smith; Danielle L Germundson; Pan Gao; Junguk Hur; Angela M Floden; Kumi Nagamoto-Combs
Journal:  Brain Behav Immun       Date:  2021-03-09       Impact factor: 19.227

5.  Cost-effectiveness of extended-release methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder sub-optimally treated with immediate release methylphenidate.

Authors:  Jurjen van der Schans; Nikos Kotsopoulos; Pieter J Hoekstra; Eelko Hak; Maarten J Postma
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

6.  Infectious, atopic and inflammatory diseases, childhood adversities and familial aggregation are independently associated with the risk for mental disorders: Results from a large Swiss epidemiological study.

Authors:  Vladeta Ajdacic-Gross; Aleksandra Aleksandrowicz; Stephanie Rodgers; Margot Mutsch; Anja Tesic; Mario Müller; Wolfram Kawohl; Wulf Rössler; Erich Seifritz; Enrique Castelao; Marie-Pierre F Strippoli; Caroline Vandeleur; Roland von Känel; Rosa Paolicelli; Markus A Landolt; Cornelia Witthauer; Roselind Lieb; Martin Preisig
Journal:  World J Psychiatry       Date:  2016-12-22

Review 7.  Elimination diets' efficacy and mechanisms in attention deficit hyperactivity disorder and autism spectrum disorder.

Authors:  Verena Ly; Marco Bottelier; Pieter J Hoekstra; Alejandro Arias Vasquez; Jan K Buitelaar; Nanda N Rommelse
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-02-11       Impact factor: 4.785

8.  Methylphenidate use and school performance among primary school children: a descriptive study.

Authors:  Jurjen van der Schans; Rukiye Çiçek; Sefike Vardar; Jens Hj Bos; Tjalling W de Vries; Pieter J Hoekstra; Eelko Hak
Journal:  BMC Psychiatry       Date:  2017-03-29       Impact factor: 3.630

Review 9.  Allergic diseases in children with attention deficit hyperactivity disorder: a systematic review and meta-analysis.

Authors:  Celine Miyazaki; Momoko Koyama; Erika Ota; Toshiyuki Swa; Linda B Mlunde; Rachel M Amiya; Yoshiyuki Tachibana; Kiwako Yamamoto-Hanada; Rintaro Mori
Journal:  BMC Psychiatry       Date:  2017-03-31       Impact factor: 3.630

10.  Risk factors for the existence of attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders.

Authors:  Anna Linda Lamanna; Francesco Craig; Emilia Matera; Marta Simone; Maura Buttiglione; Lucia Margari
Journal:  Neuropsychiatr Dis Treat       Date:  2017-06-15       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.